View in EDS HTML Full Text PDF Full Text

Lebrikizumab Improves Clinical Manifestations, Symptoms, and Quality of Life in Patients with Moderate-to-Severe Atopic Dermatitis Previously Treated with Dupilumab: Results from the ADapt Study.

Saved in:
Bibliographic Details
Title: Lebrikizumab Improves Clinical Manifestations, Symptoms, and Quality of Life in Patients with Moderate-to-Severe Atopic Dermatitis Previously Treated with Dupilumab: Results from the ADapt Study.
Authors: Silverberg, Jonathan I.1 (AUTHOR) jonathanisilverberg@gmail.com, Ackerman, Lindsay2 (AUTHOR), Bagel, Jerry3 (AUTHOR), Stein Gold, Linda4 (AUTHOR), Blauvelt, Andrew5 (AUTHOR), Rosmarin, David6 (AUTHOR), Chovatiya, Raj7,8 (AUTHOR), Zirwas, Matthew9,10,11 (AUTHOR), Yosipovitch, Gil12 (AUTHOR), Waibel, Jill13 (AUTHOR), Murase, Jenny E.14,15 (AUTHOR), Lockshin, Ben16 (AUTHOR), Weisman, Jamie17 (AUTHOR), Atwater, Amber Reck18 (AUTHOR), Proper, Jennifer18 (AUTHOR), Silk, Maria18 (AUTHOR), Pierce, Evangeline18 (AUTHOR), Piruzeli, Maria Lucia Buziqui18 (AUTHOR), Montmayeur, Sonia18 (AUTHOR), Schuster, Christopher18 (AUTHOR)
Source: Dermatology & Therapy. Feb2026, Vol. 16 Issue 2, p1309-1330. 22p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21938210
DOI:10.1007/s13555-025-01644-3